| (210) | Number of the EPO application | 16803881 |
| (220) | Filing date of the EPO application | 2016.03.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2021, 2021.10.06 |
| (110) | EPO patent number | 3303317 |
| (21) | Number of the application | e 2018 0362 |
| (71) | Name(s) of applicant(s), code of the country | Kura Oncology, Inc., US;
The Regents of The University of Michigan, US; |
| (72) | Name(s) of inventor(s), code of the country | GREMBECKA Jolanta, US;
BORKIN Dmitry, US;
CIERPICKI Tomasz, US;
POLLOCK Jonathan, US;
LI Liansheng, US;
WU Tao, US;
FENG Jun, US;
REN Pingda, US;
LIU Yi, US;
KLOSSOWSKI Szymon, US; |
| (73) | Name(s) of owner(s), code of the country | Kura Oncology, Inc., US;
The Regents of The University of Michigan, US; |
| (54) | Title of the invention | METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/04 (2006.01.01); C07D 405/10 (2006.01.01); A61P 35/04 (2006.01.01); C07D 473/34 (2006.01.01); C07D 487/04 (2006.01.01); C07D 491/048 (2006.01.01); C07D 495/04 (2006.01.01); C07D 498/04 (2006.01.01); C07D 513/04 (2006.01.01); C07D 519/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.05.31 |
| (30) | Priority | 201562171108 P, 2015.06.04, US; P160100689, 2016.03.15, AR |
| (86) | International application | PCT/US2016/022717, 2016.03.16 |
| (87) | International publication | WO 2016/195776, 2016.12.08 |